Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
27 March 2024
23:43 | Editorial Board diffhist +994 Warner-admin talk contribs |
m 19:58 | Hepatocellular carcinoma diffhist -14 Jwarner talk contribs →References |
|
m 19:56 | Multiple myeloma, induction 2 changes history +24 [Warner-admin; Jwarner] | |||
m |
|
19:56 (cur | prev) +24 Jwarner talk contribs | |||
m |
|
00:42 (cur | prev) 0 Warner-admin talk contribs Text replacement - "cycles, given" to "cycles; given" |
m 11:29 | Peripheral T-cell lymphoma diffhist -1 Jwarner talk contribs →Supportive therapy |
m 00:42 | Testicular cancer diffhist 0 Warner-admin talk contribs Text replacement - "cycles, given" to "cycles; given" |
m 00:42 | Light-chain (AL) amyloidosis diffhist 0 Warner-admin talk contribs Text replacement - "cycles, "given" to "cycles; "given" |
m 00:40 | Anaplastic large cell lymphoma diffhist 0 Warner-admin talk contribs Text replacement - ", next cycle to start" to "; next cycle to start" |
m 00:39 | Hepatoblastoma diffhist -1 Warner-admin talk contribs Text replacement - "21-day course (to be given within 42 days of resection)" to "21-day course; to be given within 42 days of resection" |
m 00:38 | Classical Hodgkin lymphoma diffhist +10 Warner-admin talk contribs Text replacement - "21- to 28-day cycles (depending on degree of myelosuppression)" to "21- to 28-day cycles; cycle length depends on degree of myelosuppression" |
m 00:37 | Colorectal cancer diffhist 0 Warner-admin talk contribs Text replacement - "14-day cycle for up to 6 cycles, then proceed to sLV5FU2:" to "14-day cycle for up to 6 cycles; then proceed to sLV5FU2:" |
|
m 00:27 | Acute promyelocytic leukemia 2 changes history -40 [Warner-admin (2×)] | |||
m |
|
00:27 (cur | prev) -32 Warner-admin talk contribs Text replacement - "One course of up to 90 days" to "Up to 90-day course" | |||
m |
|
00:27 (cur | prev) -8 Warner-admin talk contribs Text replacement - "One course of up to 60 days" to "Up to 60-day course" |
26 March 2024
|
11:23 | Esophageal squamous cell carcinoma 2 changes history +3,940 [Jwarner (2×)] | |||
|
11:23 (cur | prev) +2,061 Jwarner talk contribs →Cisplatin & Fluorouracil (CF) & Sintilimab {{#subobject:717obb|Regimen=1}} | ||||
m |
|
11:10 (cur | prev) +1,879 Jwarner talk contribs →Cisplatin & Fluorouracil (CF) {{#subobject:4d9936|Regimen=1}} |
m 01:35 | Acute promyelocytic leukemia diffhist +5 Jwarner talk contribs →Targeted therapy |
m 00:31 | Breast cancer diffhist -19 Jwarner talk contribs →Metastatic disease, subsequent lines of chemotherapy |
25 March 2024
m 01:12 | Glioblastoma diffhist +213 Jwarner talk contribs →Cyclophosphamide monotherapy {{#subobject:1724a|Regimen=1}} |
m 01:07 | Gestational trophoblastic neoplasia diffhist +43 Jwarner talk contribs →Low-risk disease, all lines of therapy |
24 March 2024
m 23:39 | Breast cancer, ER and HER2 co-expressing diffhist -192 Jwarner talk contribs |
m 20:00 | Diffuse large B-cell lymphoma diffhist -29 Jwarner talk contribs |
m 19:50 | Melanoma, BRAF-mutated diffhist +12 Jwarner talk contribs |
|
m 18:08 | Colorectal cancer, RAS wild-type 2 changes history +177 [Jwarner (2×)] | |||
m |
|
18:08 (cur | prev) +155 Jwarner talk contribs →Subsequent treatment | |||
m |
|
18:06 (cur | prev) +22 Jwarner talk contribs |
m 17:48 | Multiple myeloma, consolidation and maintenance diffhist +855 Jwarner talk contribs |
m 17:06 | Transformed lymphoma diffhist -3 Jwarner talk contribs |
m 17:04 | Thymoma diffhist -2 Jwarner talk contribs |
m 17:00 | Small cell lung cancer diffhist +24 Jwarner talk contribs |
|
m 12:03 | Urothelial carcinoma 2 changes history -50 [Jwarner (2×)] | |||
m |
|
12:03 (cur | prev) +1 Jwarner talk contribs →Regimen variant #2, AUC 4.5/1000, indefinite {{#subobject:5f0in7|Variant=1}} | |||
m |
|
12:02 (cur | prev) -51 Jwarner talk contribs →Chemotherapy |
|
m 11:42 | Non-small cell lung cancer 6 changes history +2,535 [Jwarner (6×)] | |||
m |
|
11:42 (cur | prev) +2 Jwarner talk contribs →References | |||
m |
|
11:42 (cur | prev) +2,311 Jwarner talk contribs →Carboplatin & Paclitaxel (CP) {{#subobject:81d5a7|Regimen=1}} | |||
m |
|
11:39 (cur | prev) +159 Jwarner talk contribs →Carboplatin & Paclitaxel (CP) & RT {{#subobject:899399|Regimen=1}} | |||
m |
|
11:30 (cur | prev) +114 Jwarner talk contribs →Carboplatin & Paclitaxel (CP) & RT {{#subobject:899399|Regimen=1}} | |||
m |
|
02:21 (cur | prev) -38 Jwarner talk contribs | |||
m |
|
00:24 (cur | prev) -13 Jwarner talk contribs |
|
11:24 | Neuroendocrine tumor 3 changes history +1,694 [Jwarner (3×)] | |||
|
11:24 (cur | prev) +1,644 Jwarner talk contribs →Everolimus monotherapy {{#subobject:99989f|Regimen=1}} | ||||
m |
|
11:23 (cur | prev) +54 Jwarner talk contribs →Fluorouracil & Streptozocin {{#subobject:bd8397|Regimen=1}} | |||
m |
|
11:21 (cur | prev) -4 Jwarner talk contribs →Fluorouracil & Streptozocin {{#subobject:bd8397|Regimen=1}} |
|
02:30 | Kaposi sarcoma 2 changes history +1,542 [Jwarner (2×)] | |||
m |
|
02:30 (cur | prev) +4 Jwarner talk contribs →Pegylated liposomal doxorubicin monotherapy {{#subobject:a880c2|Regimen=1}} | |||
|
02:29 (cur | prev) +1,538 Jwarner talk contribs →Bevacizumab monotherapy {{#subobject:25316e|Regimen=1}} |
m 02:21 | Malignant pleural mesothelioma diffhist -18 Jwarner talk contribs |
m 02:17 | Breast cancer diffhist +150 Jwarner talk contribs →Regimen variant #2 {{#subobject:bf8gub|Variant=1}} |
02:10 | Breast cancer, ER-positive diffhist +1,849 Jwarner talk contribs →Neoadjuvant endocrine therapy, postmenopausal |
m 00:23 | Head and neck cancer diffhist -13 Jwarner talk contribs |
m 00:22 | Non-small cell lung cancer, nonsquamous diffhist -12 Jwarner talk contribs →Tegafur & uracil monotherapy {{#subobject:ac88ea|Regimen=1}} |
23 March 2024
m 13:27 | High-grade glioma, pediatric diffhist -11 Jwarner talk contribs →Adjuvant therapy |
m 12:25 | B-cell acute lymphoblastic leukemia diffhist +2,810 Jwarner talk contribs →Relapsed or refractory |